Cargando…
A novel KRAS gene mutation report in sporadic colorectal cancer, from Northwest of Iran
While the role of KRAS gene mutations has been widely accepted for predicting responses to anti‐EGFR therapy in patients with colorectal cancer, although this study was based on observation of a single case it gives hope that some KRAS gene mutation may have favorable prognosis. More studies are req...
Autores principales: | Dolatkhah, Roya, Somi, Mohammad Hossein, Kermani, Iraj Asvadi, Farassati, Faris, Dastgiri, Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331244/ https://www.ncbi.nlm.nih.gov/pubmed/28265402 http://dx.doi.org/10.1002/ccr3.779 |
Ejemplares similares
-
Colorectal Cancer in Iran: Molecular Epidemiology and Screening Strategies
por: Dolatkhah, Roya, et al.
Publicado: (2015) -
Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis
por: Dolatkhah, Roya, et al.
Publicado: (2015) -
Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran
por: Dolatkhah, Roya, et al.
Publicado: (2016) -
Main Risk Factors Association with Proto-Oncogene Mutations in Colorectal Cancer
por: Dolatkhah, Roya, et al.
Publicado: (2018) -
Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
por: Dolatkhah, Roya, et al.
Publicado: (2021)